DaVita (DVA)
Provides dialysis and integrated kidney care across U.S. and international clinic networks.
Something off on this page? Send us feedback.
Provides outpatient, home, and hospital dialysis, related laboratory services, and integrated kidney care. Most revenue comes from U.S. dialysis; government programs cover most patients, while higher-paying commercial contracts generate nearly all dialysis profit.
Provides outpatient, home-based, and hospital inpatient dialysis for people with end-stage kidney disease, with related laboratory and administrative services. U.S. dialysis is the largest line of business, supported by a nationwide clinic network and local nephrologist relationships.
Extends beyond dialysis through Integrated Kidney Care, which coordinates chronic and end-stage kidney disease care under fee-based, shared-savings, performance, and capitated arrangements. International operations run dialysis centers across Latin America, Europe, Asia, and the Middle East, while smaller ancillary businesses cover clinical research and transplant software.
A broad care network, trained clinical staff, and data-enabled coordination support recurring treatments across care settings. Revenue depends on Medicare and other government reimbursement, higher-paying commercial contracts, patient referrals, labor and supply costs, and compliance with healthcare billing, referral, and value-based-care rules.
Company facts
Unavailable right now.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $688.9M · Total debt $10.78B · Total assets $17.71B · Shareholders' equity −$765.1M
- Revenue
- $3.55B
- Operating income
- $570.8M
- Net income
- $265.4M
No dividends on record.
Unavailable right now.
- Fresenius Medical Care (ADR)
Direct dialysis-care and products peer across clinics, home care, and VBC
- UnitedHealth Group
Integrated kidney-care overlap through Optum and UnitedHealthcare
- CVS Health
Integrated-care platform overlapping kidney value-based care
- Humana
MA-led kidney-care risk and senior primary-care overlap
- Outset Medical
Hospital/home dialysis tech challenging outsourced service models
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| DaVita | $184.19 | +1.01% | $11.71B | 16.0 | 11.7 | 0.8 | +5.2% |
| Fresenius Medical Care (ADR) | $22.53 | +1.40% | $11.94B | 11.6 | 8.7 | 0.5 | −0.7% |
| UnitedHealth Group | $374.61 | −0.78% | $342.88B | 24.3 | 17.6 | 0.8 | +0.4% |
| CVS Health | $87.69 | +0.10% | $111.77B | 23.2 | 10.8 | 0.3 | +7.3% |
| Humana | $373.31 | −1.39% | $45.39B | 35.9 | 30.3 | 0.3 | +26.2% |
| Outset Medical | $3.21 | +2.88% | $57.8M | — | — | 0.5 | +0.7% |
| Median | 23.7 | 14.2 | 0.5 | +0.7% |